Volume 27, Issue 3 (2024)
mjms 2024, 27(3): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Soleimani M. A Review of Exosome-Mediated Immunotherapy in Iran. mjms 2024; 27 (3)
URL: http://mjms.modares.ac.ir/article-30-78057-en.html
URL: http://mjms.modares.ac.ir/article-30-78057-en.html
Department of Hematology , Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran , soleim_m@modares.ac.ir
Abstract: (216 Views)
For decades, chemotherapy and radiotherapy have been considered the two main pillars of cancer treatment, but with the advent of immunotherapy, studies have been shifted towards this treatment method. The main goal of immunotherapy is to strengthen or support the patient's immune system in destroying malignant cells. From the first immunotherapy in 1981 to 2013, when immunotherapy was introduced as the "Scientific Achievement of the Year," various immunotherapy methods have been used to treat patients. Since the use of cells in therapy has always been associated with problems, the introduction of exosomes as nanoparticles that could easily reach the target tissue could greatly overcome the challenges of immunotherapy. In this review, we aimed to review studies on exosome-mediated immunotherapy. Although the studies have been shown favorable outcomes, it would be valuable to conduct research in this field that could help to better advance and solve the challenges of exosome mediated immunotherapy.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |